Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and/or dendritic cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chung, Yutein ^a   Zhang, Nan ^a,b   Wooten, R Mark ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BORRELIA BURGDORFERI; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HOST PATHOGEN INTERACTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE MIGRATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BORRELIA BURGDORFERI; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; INTERLEUKIN-10; LYME DISEASE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; PHAGOCYTOSIS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84893166598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084980     Document Type: Article

References (88)

1. Wooten RM, Weis JJ (2001) Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol 4: 274-279. doi:10.1016/S1369-5274(00)00202-2. PubMed: 11378478.
2. Radolf JD, Caimano MJ, Stevenson B, Hu LT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10: 87-99. PubMed: 22230951.
3. Benach JL, Habicht GS, Gocinski BL, Coleman JL (1984) Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete. Yale J Biol Med 57: 599-605. PubMed: 6393611.
4. Montgomery RR, Nathanson MH, Malawista SE (1994) Fc- and non-Fc-mediated phagocytosis of Borrelia burgdorferi by macrophages. J Infect Dis 170: 890-893. doi:10.1093/infdis/170.4.890. PubMed: 7930732.
5. Montgomery RR, Lusitani D, Chevance Ad Ade B, Malawista SE (2002) Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J Infect Dis 185: 1773-1779. doi:10.1086/340826. PubMed: 12085324.
6. Barthold SW, Bockenstedt LK (1993) Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61: 4696-4702. PubMed: 8406868.
7. Hastey CJ, Elsner RA, Barthold SW, Baumgarth N (2012) Delays and Diversions Mark the Development of B Cell Responses to Borrelia burgdorferi. Infection - J Immunol.
8. Weis JJ (2002) Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr Opin Rheumatol 14: 399-403. doi:10.1097/00002281-200207000- 00011. PubMed: 12118174.
9. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R et al. (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390: 580-586. doi:10.1038/37551. PubMed: 9403685.
10. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B et al. (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 490-516. PubMed: 10672174.
11. Casjens SR, Mongodin EF, Qiu WG, Luft BJ, Schutzer SE et al. (2012) Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLOS ONE 7: e33280. doi:10.1371/journal.pone.0033280. PubMed: 22432010.
12. Setubal JC, Reis M, Matsunaga J, Haake DA (2006) Lipoprotein computational prediction in spirochaetal genomes. Microbiology 152: 113-121. doi:10.1099/mic.0.28317-0. PubMed: 16385121.
13. Samuels DS (2011) Gene regulation in Borrelia burgdorferi. Annu Rev Microbiol 65: 479-499. doi:10.1146/annurev.micro.112408.134040. PubMed: 21801026.
14. Schulze RJ, Zückert WR (2006) Borrelia burgdorferi lipoproteins are secreted to the outer surface by default. Mol Microbiol 59: 1473-1484. doi:10.1111/j.1365-2958.2006.05039.x. PubMed: 16468989.
15. Kenedy MR, Lenhart TR, Akins DR (2012) The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol 66: 1-19. doi:10.1111/j.1574-695X.2012.00980.x. PubMed: 22540535.
16. Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R et al. (1998) The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 160: 5485-5492. PubMed: 9605151.
17. Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J et al. (1998) Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol 160: 5455-5464. PubMed: 9605148.
18. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH et al. (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 163: 2382-2386. PubMed: 10452971.
19. Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ et al. (2004) MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173: 2003-2010. PubMed: 15265935.
20. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G et al. (1999) Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274: 33419-33425. doi:10.1074/jbc.274.47.33419. PubMed: 10559223.
21. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH et al. (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168: 348-355. PubMed: 11751980.
22. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK (2004) Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72: 3195-3203. doi:10.1128/IAI.72.6.3195-3203.2004. PubMed: 15155621.
23. Salazar JC, Pope CD, Moore MW, Pope J, Kiely TG et al. (2005) Lipoprotein-dependent and -independent immune responses to spirochetal infection. Clin Diagn Lab Immunol 12: 949-958. PubMed: 16085913.
24. Thoma-Uszynski S, Kiertscher SM, Ochoa MT, Bouis DA, Norgard MV et al. (2000) Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165: 3804-3810. PubMed: 11034386.
25. Morrison TB, Weis JH, Weis JJ (1997) Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J Immunol 158: 4838-4845. PubMed: 9144499.
26. Marietta EV, Weis JJ, Weis JH (1997) CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi. J Immunol 159: 2840-2848. PubMed: 9300707.
27. Ma Y, Weis JJ (1993) Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 61: 3843-3853. PubMed: 8359905.
28. Wooten RM, Modur VR, McIntyre TM, Weis JJ (1996) Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-κB and inflammatory activation in human endothelial cells. J Immunol 157: 4584-4590. PubMed: 8906837.
29. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S (1997) Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 158: 3285-3292. PubMed: 9120285.
30. Yoder A, Wang X, Ma Y, Philipp MT, Heilbrun M et al. (2003) Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge. Infect Immun 71: 3894-3900. doi:10.1128/IAI.71.7.3894- 3900.2003. PubMed: 12819074.
31. Iliopoulou BP, Huber BT (2010) Infectious arthritis and immune dysregulation: lessons from Lyme disease. Curr Opin Rheumatol 22: 451-455. doi:10.1097/BOR.0b013e328338f73f. PubMed: 20375899.
32. Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218. doi:10.1111/j.1600-065X.2008.00706.x. PubMed: 19161426.
33. Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E et al. (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21: 331-344. doi:10.1016/j.cytogfr.2010.09.002. PubMed: 21115385.
34. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29: 71-109. doi:10.1146/annurev-immunol-031210-101312. PubMed: 21166540.
35. Giambartolomei GH, Dennis VA, Philipp MT (1998) Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immun 66: 2691-2697. PubMed: 9596735.
36. Giambartolomei GH, Dennis VA, Lasater BL, Philipp MT (1999) Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun 67: 140-147. PubMed: 9864208.
37. Brown JP, Zachary JF, Teuscher C, Weis JJ, Wooten RM (1999) Dual role of interleukin-10 in murine Lyme disease: Regulation of arthritis severity and host defense. Infect Immun 67: 5142-5150. PubMed: 10496888.
38. Gautam A, Dixit S, Embers M, Gautam R, Philipp MT et al. (2012) Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice. PLOS ONE 7: e43860. doi:10.1371/journal.pone.0043860. PubMed: 23024745.
39. Crandall H, Dunn DM, Ma Y, Wooten RM, Zachary JF et al. (2006) Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J Immunol 177: 7930-7942. PubMed: 17114465.
40. Sonderegger FL, Ma Y, Maylor-Hagan H, Brewster J, Huang X et al. (2012) Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFNγ-mediated Lyme arthritis. J Immunol 188: 1381-1393. doi:10.4049/jimmunol.1102359. PubMed: 22180617.
41. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM (2006) IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 177: 7076-7085. PubMed: 17082624.
42. Lazarus JJ, Kay MA, McCarter AL, Wooten RM (2008) Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun 76: 1153-1162. doi:10.1128/IAI.01404-07. PubMed: 18086805.
43. Nestle FO; Di Meglio P, Qin JZ, Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9: 679-691. PubMed: 19763149. Available online at: PubMed: 19763149
44. Weis JJ, Bockenstedt LK, editors (2010) Borrelia: Molecular Biology, Host Interaction, and Pathogenesis. Norfolk, UK: Caister Academic Press. pp. 413-441.
45. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD (1990) Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162: 133-138. doi:10.1093/infdis/162.1.133. PubMed: 2141344.
46. Barbour AG (1984) Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57: 521-525. PubMed: 6393604.
47. Miller JC, von Lackum K, Woodman ME, Stevenson B (2006) Detection of Borrelia burgdorferi gene expression during mammalian infection using transcriptional fusions that produce green fluorescent protein. Microb Pathog 41: 43-47. doi:10.1016/j.micpath.2006.04.004. PubMed: 16723206.
48. Matsushima H, Tanaka H, Mizumoto N, Takashima A (2009) Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells. Blood 114: 64-73. doi:10.1182/blood-2009-02- 204297. PubMed: 19401559.
49. Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412. PubMed: 3139757.
50. Xu Q, Seemanapalli SV, Reif KE, Brown CR, Liang FT (2007) Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity. J Immunol 178: 5109-5115. PubMed: 17404293.
51. Montgomery RR, Lusitani D, De Boisfleury Chevance A, Malawista SE (2004) Tick saliva reduces adherence and area of human neutrophils. Infect Immun 72: 2989-2994. doi:10.1128/IAI.72.5.2989-2994.2004. PubMed: 15102811.
52. Cinco M, Murgia R, Perticarari S, Presani G (1994) Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol Lett 122: 187-193. doi:10.1111/j.1574-6968.1994.tb07163.x. PubMed: 7958771.
53. Marangoni A, Accardo S, Aldini R, Guardigli M, Cavrini F et al. (2006) Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi. World J Gastroenterol 12: 3077-3081. PubMed: 16718791.
54. Giambartolomei GH, Dennis VA, Lasater BL, Murthy PK, Philipp MT (2002) Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 70: 1881-1888. doi:10.1128/IAI.70.4.1881-1888.2002. PubMed: 11895951.
55. Gautam A, Dixit S, Philipp MT, Singh SR, Morici LA et al. (2011) Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun 79: 4876-4892. doi:10.1128/IAI.05451-11. PubMed: 21947773.
56. Shin OS, Isberg RR, Akira S, Uematsu S, Behera AK et al. (2008) Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect Immun 76: 2341-2351. doi:10.1128/IAI.01600-07. PubMed: 18378636.
57. Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW et al. (2009) Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFNβ. PLOS Pathog 5: e1000444.
58. Montgomery RR, Malawista SE (1996) Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect Immun 64: 2867-2872. PubMed: 8698527.
59. Nathan CF, Hibbs JB Jr. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70. doi:10.1016/0952-7915(91)90079-G. PubMed: 1711326.
60. Dale DC, Boxer L, Liles WC (2008) The phagocytes: neutrophils and monocytes. Blood 112: 935-945. doi:10.1182/blood-2007-12-077917. PubMed: 18684880.
61. Flannagan RS, Cosío G, Grinstein S (2009) Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 7: 355-366. doi:10.1038/nrmicro2128. PubMed: 19369951.
62. Moreira AP, Dias-Melicio LA, Soares AM (2010) Interleukin-10 but not Transforming Growth Factor beta inhibits murine activated macrophages Paracoccidioides brasiliensis killing: effect on H2O2 and NO production. Cell Immunol 263: 196-203. doi:10.1016/j.cellimm.2010.03.016. PubMed: 20417928.
63. Boylan JA, Gherardini FC (2008) Determining the cellular targets of reactive oxygen species in Borrelia burgdorferi. Methods Mol Biol 431: 213-221. PubMed: 18287759.
64. Boylan JA, Lawrence KA, Downey JS, Gherardini FC (2008) Borrelia burgdorferi membranes are the primary targets of reactive oxygen species. Mol Microbiol 68: 786-799. doi:10.1111/j.1365-2958.2008.06204.x. PubMed: 18373524.
65. Seiler KP, Vavrin Z, Eichwald E, Hibbs JB Jr., Weis JJ (1995) Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun 63: 3886-3895. PubMed: 7558296.
66. Ma Y, Seiler KP, Tai KF, Yang L, Woods M et al. (1994) Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun 62: 3663-3671. PubMed: 7520417.
67. Shortman K, Naik SH (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30. doi:10.1038/nri1996. PubMed: 17170756.
68. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70. doi:10.1016/S1074-7613(03)00171-7. PubMed: 12871639.
69. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661. doi:10.1126/science.1178331. PubMed: 20133564.
70. Cortez-Retamozo V, Etzrodt M, Pittet MJ (2012) Regulation of macrophage and dendritic cell responses by their lineage precursors. J Innate Immun 4: 411-423. doi:10.1159/000335733. PubMed: 22433183.
71. Crandall H, Ma Y, Dunn DM, Sundsbak RS, Zachary JF et al. (2005) Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase. Am J Pathol 167: 775-785. doi:10.1016/S0002-9440(10)62050-0. PubMed: 16127156.
72. Brown CR, Reiner SL (1999) Development of lyme arthritis in mice deficient in inducible nitric oxide synthase. J Infect Dis 179: 1573-1576. doi:10.1086/314774. PubMed: 10228086.
73. Bourret TJ, Boylan JA, Lawrence KA, Gherardini FC (2011) Nitrosative damage to free and zinc-bound cysteine thiols underlies nitric oxide toxicity in wild-type Borrelia burgdorferi. Mol Microbiol 81: 259-273. doi:10.1111/j.1365- 2958.2011.07691.x. PubMed: 21564333.
74. Esteve-Gassent MD, Elliott NL, Seshu J (2009) sodA is essential for virulence of Borrelia burgdorferi in the murine model of Lyme disease. Mol Microbiol 71: 594-612. doi:10.1111/j.1365-2958.2008.06549.x. PubMed: 19040638.
75. Posey JE, Gherardini FC (2000) Lack of a role for iron in the Lyme disease pathogen. Science 288: 1651-1653. doi:10.1126/science.288.5471.1651. PubMed: 10834845.
76. Behera AK, Hildebrand E, Bronson RT, Perides G, Uematsu S et al. (2006) MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun 74: 1462-1470. doi:10.1128/IAI.74.3.1462-1470.2006. PubMed: 16495516.
77. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986. doi:10.1038/ni1380. PubMed: 16921381.
78. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA (2010) Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw 21: 7-18. PubMed: 20146985.
79. Singh SK, Girschick HJ (2006) Toll-like receptors in Borrelia burgdorferi-induced inflammation. Clin Microbiol Infect 12: 705-717. PubMed: 16842565.
80. Bouis DA, Popova TG, Takashima A, Norgard MV (2001) Dendritic cells phagocytose and are activated by Treponema pallidum. Infect Immun 69: 518-528. doi:10.1128/IAI.69.1.518-528.2001. PubMed: 11119545.
81. Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK (2003) Interaction between Borrelia burgdorferi and immature human dendritic cells. Scand J Immunol 58: 67-75. doi:10.1046/j.1365-3083.2003.01284.x. PubMed: 12828560.
82. Miller JC, Ma Y, Bian J, Sheehan KC, Zachary JF et al. (2008) A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J Immunol 181: 8492-8503. PubMed: 19050267.
83. Barthold SW (1996) Lyme borreliosis in the laboratory mouse. Journal Spirochetal and Tick-Borne Diseases 3: 22-44.
84. Steinman RM, Idoyaga J (2010) Features of the dendritic cell lineage. Immunol Rev 234: 5-17. doi:10.1111/j.0105-2896.2009.00888.x. PubMed: 20193008.
85. Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunol Rev 234: 45-54. doi:10.1111/j.0105-2896.2009.00879.x. PubMed: 20193011.
86. Hume DA (2008) Macrophages as APC and the dendritic cell myth. J Immunol 181: 5829-5835. PubMed: 18941170.
87. Barthold SW, deSouza M, Feng S (1996) Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 74: 57-67. PubMed: 8569198.
88. Shanafelt MC, Kang I, Barthold SW, Bockenstedt LK (1998) Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immun 66: 266-271. PubMed: 9423867.